Novel substituted benzothiazole and Imidazo[2,1-b][1,3,4]Thiadiazole derivatives: Synthesis, characterization, molecular docking study, and investigation of their in vitro antileishmanial and antibacterial activities
作者:Mustafa Er、Arif Özer、Şahin Direkel、Tuncay Karakurt、Hakan Tahtaci
DOI:10.1016/j.molstruc.2019.05.104
日期:2019.10
thiosemicarbazide in trifluoroacetic acid (TFA) (in yields of 83% and 84%). Finally, we synthesized the imidazo[2,1-b][1,3,4]thiadiazole derivatives (5-24) containing benzothiazole group, which are the target compounds, from reactions of 2-amino-1,3,4-thiadiazole derivatives (4a,b) with phenacyl bromide derivatives (in yields of 53%–73%). All of the compounds synthesized were characterized with 1H NMR, 13C NMR
摘要 本研究合成了新型的含苯并噻唑基团的咪唑并[2,1-b][1,3,4]噻二唑衍生物。为此,我们首先以高产率(分别为 82% 和 87%)获得了原料苯并[d]噻唑-2-基硫基/氧基乙腈化合物(3a,b)。然后,我们通过这些腈衍生物 (3a,b) 与氨基硫脲在三氟乙酸 (TFA) 中的反应合成了 2-氨基-1, 3,4-噻二唑衍生物 (4a,b)(产率分别为 83% 和 84 %)。最后,我们从2-氨基-1,3,4-的反应中合成了目标化合物含有苯并噻唑基团的咪唑并[2,1-b][1,3,4]噻二唑衍生物(5-24)。噻二唑衍生物 (4a,b) 与苯甲酰溴衍生物(产率为 53%–73%)。合成的所有化合物均经 1H NMR、13C NMR、FT-IR、元素分析、和质谱。对研究中合成的化合物进行了抗利什曼原虫和抗菌活性测试。据观察,化合物 8 具有最高的抗利什曼原虫活性(MIC = 10 000